Nonalcoholic Steatohepatitis (NASH) Has Surpassed Hepatitis C as the Leading Etiology for Listing for Liver Transplant: Implications for NASH in Children and Young Adults

被引：0
|
作者：
Banini, Bubu A. [1 ]
Mota, Manoela [1 ]
Behnke, Martha [2 ]
Sharma, Amit [1 ]
Sanyal, Arun J. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Syst Imaginat Inc, Scottsdale, AZ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-00755
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
755
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 44 条
  • [31] Is severity of inflammation or firosis in chronic hepatitis C (CHC) aggrevated by non-alcoholic fatty liver (NAFL) or steatohepatitis (NASH)?.
    Lee, Y
    Lebovics, E
    Bloom, P
    Mackey, J
    Elhosseiny, A
    Hirsch, J
    Kaza, C
    Ligresti, R
    Rigas, B
    HEPATOLOGY, 2002, 36 (04) : 559A - 559A
  • [32] Liver Transplant in Young Adults with Chronic Hepatitis C Virus: An Argument for Hepatitis C Treatment in Childhood
    Mohamad, Bashar
    Hanouneh, Ibrahim A.
    Zein, Nizar N.
    Lopez, Rocio
    Matloob, Ammar
    Alkhouri, Naim
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (02) : 201 - 206
  • [33] NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST RAPIDLY GROWING CAUSE OF LISTING FOR LIVER TRANSPLANTATION: THE SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR) DATA FROM 1994 TO 2018
    Younossi, Zobair M.
    Stepanova, Maria
    Ong, Janus
    Trimble, Gregory
    Ahmed, Aijaz
    Alqahtani, Saleh
    Younossi, Issah
    Racila, Andrei
    HEPATOLOGY, 2019, 70 : 697A - 698A
  • [34] POST LIVER TRANSPLANT SURVIVAL AMONG HISPANIC AND NON-HISPANIC WHITE PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH): AN ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK (OPTN) ANALYSIS
    Shah, Pankil
    Noureddin, Mazen
    Alkhouri, Naim
    HEPATOLOGY, 2023, 78 : S1028 - S1030
  • [35] NONALCOHOLIC STEATOHEPATITIS SURPASSES CHRONIC HEPATITIS C VIRUS TO BECOME THE LEADING INDICATION FOR LIVER TRANSPLANTATION WAITLIST REGISTRATION AMONG US ADULTS BORN BETWEEN 1945-1965
    Shirazi, Farah
    Wang, Jennifer
    Wong, Robert J.
    GASTROENTEROLOGY, 2018, 154 (06) : S1141 - S1141
  • [36] Labcorp Data in >19,000 Children with a Diagnosis Code for T2D Show Predominantly Normal Liver Function Tests: Implications for Identifying Nonalcoholic Fatty Liver Disease or Steatohepatitis (NAFLD/NASH)
    Puri, Mala
    Lizzi-Ansok, Karina M.
    Filozof, Claudia M.
    Goldstein, Barry J.
    DIABETES, 2020, 69
  • [37] METABOLIC ABNORMALITIES AND ATHEROSCLEROSIS: NASH AND LIVER ABNORMALITIES. COMPARATIVE ANALYSIS OF SERUM LIPIDS IN PATIENTS WITH CHRONIC HEPATITIS C, NONALCOHOLIC FATTY LIVER DISEASE, AND HEALTHY CONTROLS
    Ivanova, R.
    Valkov, I.
    Marinova, C.
    Alexiev, A.
    Antonov, K.
    Jelev, D.
    Mateva, L.
    ATHEROSCLEROSIS, 2016, 252 : E154 - E155
  • [38] Green tea polyphenols improve liver injury of nonalcoholic steatohepatitis (NASH) model mice expressing nuclear sterol regulatory element-binding protein 1c (nSREBP-1c) in adipose tissue
    Ueno, Takato
    Nakamura, Toru
    Sakata, Ryuichiro
    Hashimoto, Osamu
    Inoue, Kinya
    Koga, Hironori
    Torimura, Takuji
    Shinkawa, Masako
    Nakayama, Hitomi
    Otabe, Syuichi
    Hirota, Naotoshi
    Yamada, Kentaro
    Sata, Michio
    HEPATOLOGY, 2007, 46 (04) : 766A - 766A
  • [39] Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy
    Vaziri, Arash
    Gimson, Alexander
    Agarwal, Kosh
    Aldersley, Mark
    Bathgate, Andrew
    MacDonald, Douglas
    McPherson, Stuart
    Mutimer, David
    Gelson, William
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (02) : 231 - 235
  • [40] REAL-WORLD EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH DIRECT-ACTING ANTIVIRALS (DAA) IN POPULATIONS WITH FATTY LIVER/NON-ALCOHOLIC STEATOHEPATITIS (FL/NASH), DECOMPENSATED CIRRHOSIS (DCC), HEPATOCELLULAR CARCINOMA (HCC), AND/OR POST LIVER TRANSPLANT (PTX)
    Younossi, Z.
    Bacon, B.
    Curry, M.
    Flamm, S. L.
    Frick, A.
    Milligan, S.
    Radtchenko, J.
    Tsai, N.
    Afdhal, N.
    VALUE IN HEALTH, 2020, 23 : S168 - S168
12345